Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Peer Review reports

Original Submission
4 Sep 2020	Submitted	Original manuscript
9 Sep 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
10 Sep 2020	Editorially accepted
26 Oct 2020	Article published	10.1186/s13063-020-04737-w

Back to article page